29 results
424B5
TLSA
Tiziana Life Sciences Ltd
1 Sep 23
Prospectus supplement for primary offering
5:16pm
to the Nasdaq corporate governance requirements. As a result, the regulatory and compliance costs to us may be significantly higher if we cease to qualify … common stock with a market value of at least $1 million;
300 round-lot stockholders; and
compliance with Nasdaq’s corporate governance requirements
F-3/A
TLSA
Tiziana Life Sciences Ltd
25 Feb 22
Shelf registration (foreign) (amended)
4:10pm
. securities laws as well as certain Nasdaq corporate governance rules applicable to U.S. listed companies and are permitted to file less information
F-3/A
TLSA
Tiziana Life Sciences Ltd
1 Feb 22
Shelf registration (foreign) (amended)
4:15pm
laws as well as certain Nasdaq corporate governance rules applicable to U.S. listed companies and are permitted to file less information with the SEC
8-K12B
EX-10.3
z5gkxz4iww1xz9xb
21 Oct 21
Notification of registration of securities
9:17am
8-K12B
q3a8 3cja5sd0
21 Oct 21
Notification of registration of securities
9:17am
F-3
nzw4tze gc
26 Jan 21
Shelf registration (foreign)
5:31pm
6-K
EX-99.2
j7un6 6ii5d3kl
16 Sep 20
Tiziana Life Sciences Announces Planned Spin Out of StemPrintER into a New Publicly Listed Company, AccuStem Sciences
6:04am
424B5
tol2p1vecl 71l5l
4 Aug 20
Prospectus supplement for primary offering
4:35pm
6-K
EX-1.1
r4guzf7o sfndot
14 Apr 20
Current report (foreign)
8:46am
424B5
05s17j
10 Apr 20
Prospectus supplement for primary offering
5:22pm
424B5
vylcxp27y1 va
14 Feb 20
Prospectus supplement for primary offering
12:00am
F-1/A
20mu0ybypmlm 3kd
20 Sep 19
Registration statement (foreign) (amended)
4:51pm
F-1/A
y52ghjh lgvcq3g908
17 Sep 19
Registration statement (foreign) (amended)
5:19pm
F-1
fxvcnzy0 dn
5 Aug 19
Registration statement (foreign)
4:28pm
F-1
EX-1.1
cpof 76af7o
5 Aug 19
Registration statement (foreign)
4:28pm
DRS
EX-1.1
t8k0f41xwu
17 Jul 19
Draft registration statement
12:00am